Inhibition of GPX4 induces the death of p53-mutant triple-negative breast cancer cells
{{output}}
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by high rates of tumor protein 53 (TP53) mutation and with limited targeted therapies. Despite being clinically advantageous... ...
